Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000231998 | SCV000290083 | likely benign | Alstrom syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000734011 | SCV000862120 | uncertain significance | not provided | 2018-07-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000734011 | SCV001812466 | likely benign | not provided | 2020-03-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450702 | SCV002612143 | likely benign | Cardiovascular phenotype | 2021-10-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000231998 | SCV002080478 | likely benign | Alstrom syndrome | 2020-08-12 | no assertion criteria provided | clinical testing |